Serotonin, personality and borderline personality disorder

Area of Science:

• Neuroscience
• Psychiatry
• Genetics

Background:

• Serotonin is a neurotransmitter linked to personality traits and psychopathological disorders.
• Previous studies show inconsistent findings regarding serotonin activity and personality dimensions, including harm avoidance.
• Borderline personality disorder (BPD) is associated with serotonergic dysregulation, manifesting in symptoms like affective lability and impulsivity.

Purpose of the Study:

• To investigate the association between serotonin activity and personality dimensions.
• To explore the role of serotonergic dysfunction in borderline personality disorder (BPD).
• To assess serotonergic activity in BPD patients using a specific challenge test.

Main Methods:

• Review of psychobiological models of personality and serotonin.
• Analysis of correlation and genetic studies on serotonin and personality.
• Administration of the flesinoxan challenge test to assess serotonergic activity in BPD patients and controls.

Main Results:

• Correlation studies between serotonin activity and personality dimensions have yielded inconsistent results.
• Genetic studies on personality dimensions and serotonergic receptor polymorphisms show mixed findings.
• Preliminary results indicate significantly lower prolactin responses to flesinoxan in BPD patients compared to controls, suggesting reduced serotonergic activity.

Conclusions:

• Serotonergic dysfunction is implicated in borderline personality disorder (BPD).
• The flesinoxan challenge test may provide a more specific assessment of serotonergic activity in BPD.
• Further research is needed to elucidate the complex relationship between serotonin, personality, and BPD.